Cell kinetic studies in patients with small cell carcinoma of the lung
β Scribed by Franco M. Muggia; Susan K. Krezoski; Heine H. Hansen
- Publisher
- John Wiley and Sons
- Year
- 1974
- Tongue
- English
- Weight
- 697 KB
- Volume
- 34
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract ## BACKGROUND Neurologic complications are an important cause of morbidity and possibly also mortality in patients with small cell lung carcinoma (SCLC). The current study was undertaken to prospectively investigate survival and the frequency of neurologic disorders in patients with SC
## Abstract ## BACKGROUND. The study was conducted with the aim of reviewing the clinical features, therapy, and natural course of patients with extrapulmonary smallβcell carcinoma (EPSCC) and smallβcell lung carcinoma (SCLC) to better define current concepts regarding EPSCCs. ## METHODS. The me
The COPP regimen (cyclophosphamide, Oncovin, procarbazine, prednisone) was one of the first chemotherapy programs to prolong survival in small cell lung cancer (SCLC) significantly. Results with this regimen in 50 patients with SCLC show an overall median survival of 10 months. Survival was decrease